Artwork

Konten disediakan oleh U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns

2:00
 
Bagikan
 

Manage episode 428438402 series 3017434
Konten disediakan oleh U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma (FL)
  continue reading

62 episode

Artwork
iconBagikan
 
Manage episode 428438402 series 3017434
Konten disediakan oleh U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma (FL)
  continue reading

62 episode

Tüm bölümler

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat